The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | J | Antiinfectives for systemic use | |
| 2 | J04 | Antimycobacterials | |
| 3 | J04A | Drugs for treatment of tuberculosis | |
| 4 | J04AK | Other drugs for treatment of tuberculosis | |
| 5 | J04AK08 |
| Active Ingredient | Description | |
|---|---|---|
| Pretomanid |
The mechanism of action of pretomanid is thought to involve inhibition of the synthesis of cell wall lipids under aerobic conditions and generation of reactive nitrogen species under anaerobic conditions. Reductive activation of pretomanid by a mycobacterial deazaflavin (F420)-dependent nitro-reductase is required for activity under both aerobic and anaerobic conditions. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| DOVPRELA Tablet | European Medicines Agency (EU) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
